The Board proposes the development of a rule amendment to set forth conditions under which physicians do not need to keep dantrolene in office surgery facilities.  


  • RULE NO.: RULE TITLE:
    64B8-9.009: Standard of Care for Office Surgery
    PURPOSE AND EFFECT: The Board proposes the development of a rule amendment to set forth conditions under which physicians do not need to keep dantrolene in office surgery facilities.
    SUBJECT AREA TO BE ADDRESSED: The clarification of conditions under which dantrolene is not necessary in office surgery settings.
    RULEMAKING AUTHORITY: 458.309(1), 458.331(1)(v) FS.
    LAW IMPLEMENTED: 458.331(1)(v), 458.351 FS.
    IF REQUESTED IN WRITING AND NOT DEEMED UNNECESSARY BY THE AGENCY HEAD, A RULE DEVELOPMENT WORKSHOP WILL BE NOTICED IN THE NEXT AVAILABLE FLORIDA ADMINISTRATIVE WEEKLY.
    THE PERSON TO BE CONTACTED REGARDING THE PROPOSED RULE DEVELOPMENT AND A COPY OF THE PRELIMINARY DRAFT, IF AVAILABLE, IS: Joy A. Tootle, Executive Director, Board of Medicine/MQA, 4052 Bald Cypress Way, Bin #C03, Tallahassee, Florida 32399-3253

    THE PRELIMINARY TEXT OF THE PROPOSED RULE DEVELOPMENT IS AVAILABLE AT NO CHARGE FROM THE CONTACT PERSON LISTED ABOVE.

Document Information

Subject:
The clarification of conditions under which dantrolene is not necessary in office surgery settings.
Purpose:
The Board proposes the development of a rule amendment to set forth conditions under which physicians do not need to keep dantrolene in office surgery facilities.
Rulemaking Authority:
458.309(1), 458.331(1)(v) FS.
Law:
458.331(1)(v), 458.351 FS.
Contact:
Joy A. Tootle, Executive Director, Board of Medicine/MQA, 4052 Bald Cypress Way, Bin #C03, Tallahassee, Florida 32399-3253
Related Rules: (1)
64B8-9.009. Standard of Care for Office Surgery